10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The treatment of neuroinfectious diseases depends on the underlying cause and may involve antimicrobial agents, antiviral medications, or antifungal drugs. In Bacterial Meningitis, prompt administration of antibiotics is crucial to prevent severe complications such as brain damage or death. Antiviral Drugs play a key role in managing viral encephalitis, while antiparasitic and antifungal medications are employed for infections like cerebral toxoplasmosis or fungal meningitis. Complications of neuroinfectious diseases can be severe and may include long-term neurological sequelae, cognitive impairment, and, in some cases, chronic disability. Rehabilitation and supportive care are often integral components of managing complications and optimizing patient outcomes. Prevention strategies for neuroinfectious diseases include vaccination against specific pathogens known to cause these infections, such as the meningococcal vaccine, the Japanese encephalitis vaccine, or the varicella-zoster vaccine. Additionally, practicing good hygiene, avoiding exposure to vectors in endemic regions, and implementing public health measures contribute to preventing the spread of neuroinfectious diseases. Ongoing research in neuroinfectious diseases focuses on understanding the pathogenesis of these infections, developing novel diagnostic tools, and exploring innovative treatment approaches. The interdisciplinary collaboration between neurologists, infectious disease specialists, microbiologists, and public health experts is essential for advancing our knowledge and improving the management and prevention of neuroinfectious diseases.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States